Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new revision of the page without changing its visible content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s footer shows a site release/version bump from **Revision: v3.5.2** to **Revision: v3.5.3**. Additionally, the “related topics” section content that included “Multiple myeloma” and MedlinePlus Genetics appears to have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded 'Multiple myeloma' as a topic and included a related topic link to MedlinePlus Genetics.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded Revision: v3.5.0; removed related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and the reference 'Revision: v3.4.3'.SummaryDifference0.2%

- Check78 days agoChange DetectedAdded related topics for Multiple myeloma and MedlinePlus Genetics on the study page to improve navigation and context.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.